The overall results of current treatments for acute myeloid leukemia m2 are promising. Its complete remission rate after treatment is 75% to 85%. However, the complete remission rate will vary according to the specific typing. 1. The complete remission rate in the group with no chromosomal abnormality>80%. 2. The complete remission rate of patients with t(8;21) abnormality>85%. 3. Complete remission rate of patients with t(8;21) additional other chromosomal abnormalities>70%. 4. The complete remission rate of patients with t(8;21) alone can reach 100%. 5. AML-M2 patients with no karyotype abnormality have a complete remission rate of >20%. Complete remission means that the signs and symptoms of leukemia disappear, there are no primitive cells in the peripheral blood, there is no extramedullary leukemia, and the hematopoiesis of the three lineages of the bone marrow is restored. If you are diagnosed with this disease, please go to the hospital in time and follow the doctor’s instructions for standardized treatment. Medications include cytarabine and Zoerythromycin.